I can't really understand that. Three weeks ago you made a very positive post about Hims.
I understand that the pill has "broken your trust". But the fact that Hims medicines are designed very closely to those of the competition is nothing really new.
I understand that the pill has "broken your trust". But the fact that Hims medicines are designed very closely to those of the competition is nothing really new.
•
77
•
@Investor19 That is correct and I stand by it. I always try to rethink my position and take all the information into account. That's why the exchange here is important to me. The share has not bottomed out in the last three weeks. In addition, it makes a difference whether I copy medication in times of shortage or deliberately outside of it. It was an issue with the syringes. Now both $NOVO B and $LLY are under attack, and with quasi copycat preparations in tablet form. That makes me rethink things.
•
22
•